Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Archives of Internal Medicine|March 1, 1982
The value of measuring percent high-density lipoprotein in assessing risk of cardiovascular diseaseI Lipinska, V GurewichMagnesium Research|January 12, 2001
Effect of magnesium on fibrin formation from lower molecular weight (LMW) fibrinogenB Lipinski, I LipinskaThe Journal of Laboratory and Clinical Medicine|July 1, 1977
Abnormal fibrinogen heterogeneity and fibrinolytic activity in advanced liver diseaseB Lipinski, I Lipinska, A Nowak, et al.American Journal of Clinical Pathology|December 1, 1976
Fibrinogen heterogeneity in cancer, in occlusive vascular disease, and after surgical proceduresI Lipinska, B Lipinski, V Gurewich, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 1999
Comparison of plasminogen activator inhibitor-1 concentration in insulin-resistant versus insulin-sensitive healthy womenF Abbasi, T McLaughlin, C Lamendola, et al.Journal of Cardiovascular Risk|April 1, 1996
Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and womenP M Ridker, C H Hennekens, G H Tofler, et al.Journal of Thrombosis and Thrombolysis|December 10, 1999
Effect of short-term aspirin use on C-reactive proteinD Feng, R P Tracy, I Lipinska, et al.Journal of Interventional Cardiology|June 11, 2002
Transatrial access to the normal pericardial space for local cardiac therapy: preclinical safety testing with aspirin and pulmonary artery hypertensionT C Pulerwitz, S Waxman, K A Rowe, et al.Thrombosis Research|October 29, 2000
The effect of vitamin C supplementation on coagulability and lipid levels in healthy male subjectsG H Tofler, J J Stec, I Stubbe, et al.Artery|January 1, 1987
Lipids, lipoproteins, fibrinogen and fibrinolytic activity in angiographically assessed coronary heart diseaseI Lipinska, V Gurewich, C M Meriam, et al.Pageof 4